MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells indicating a key role of ERK in hepatic VLDL-apoB assembly

被引：0
|
作者：
Tsai, J [1 ]
Qiu, W [1 ]
Kohen, R [1 ]
Adeli, K [1 ]
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2006年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E67 / E67
页数：1
相关论文
共 9 条
  • [1] MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells - Potential role of ERK in VLDL-ApoB100 particle assembly
    Tsai, Julie
    Qiu, Wei
    Kohen-Avramoglu, Rita
    Adeli, Khosrow
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (01) : 211 - 218
  • [2] The assembly of apoB containing VLDL in McA-RH7777 and HepG2 cells.
    Lindberg, K
    Lindholm, M
    Rustaeus, S
    Wettesten, M
    Asp, L
    Adeli, K
    Olofsson, SO
    CIRCULATION, 1996, 94 (08) : 2016 - 2016
  • [3] Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway
    Fisher, Eric A.
    Khanna, Neeraj A.
    McLeod, Roger S.
    JOURNAL OF LIPID RESEARCH, 2011, 52 (06) : 1170 - 1180
  • [4] Inhibition of MEK/ERK1/2 Signaling Affects the Fatty Acid Composition of HepG2 Human Hepatic Cell Line
    Yousefi, Bahman
    Darabi, Masoud
    Baradaran, Behzad
    Khaniani, Mahmoud Shekari
    Rahbani, Mohammad
    Darabi, Maryam
    Fayezi, Shabnam
    Mehdizadeh, Amir
    Saliani, Negar
    Shaaker, Maghsod
    BIOIMPACTS, 2012, 2 (03) : 145 - 150
  • [5] Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells
    Tong Yongxi
    Huang Haijun
    Pan Hongying
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 456 (01) : 86 - 91
  • [6] Inhibition of the MAPK/ERK pathway potentiates TGF-beta-induced apoptosis in Hepg2 cells:: Role of oxidative stress
    Sancho, Patricia
    Caja, Laia
    Bertran, Esther
    Iglesias, Daniel
    Gil, Joan
    Fabregat, Isabel
    FREE RADICAL RESEARCH, 2007, 41 : S53 - S53
  • [7] Quercetin suppresses the chymotrypsin-like activity of proteasome via inhibition of MEK1/ERK1/2 signaling pathway in hepatocellular carcinoma HepG2 cells
    Ding, Youming
    Chen, Xiaoyan
    Wang, Bin
    Yu, Bin
    Ge, Jianhui
    Shi, Xiaokang
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2018, 96 (05) : 521 - 526
  • [8] Naringenin mimics the kinetics of insulin-induced inhibition of ApoB100-Containing lipoprotein assembly in HepG2 cells through a mechanism independent of the insulin receptor
    Allister, EM
    Edwards, JY
    Barrett, PHR
    Mulvihill, EE
    Huff, MW
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) : E53 - E54
  • [9] ERK1/2 MAPK signaling promoted assembly formation of p27kip1 with CycE:CDK2 leading to G1 cell cycle arrest in HGF-treated HepG2 cells.
    Nagahara, H
    Kogiso, T
    Shiratori, K
    HEPATOLOGY, 2003, 38 (04) : 566A - 566A
1